We therefore investigated the correlation between Src expression at the plasma membrane and HER2-positivity or activated HER receptors, and found that expression of Src was significantly associated with both HER2 positivity and expression of activated HER1-3 in the breast tumors (Table 1). This evidence concerns the gene ERBB2 and breast neoplasm.